MicroRNA-26a acts as a tumor suppressor inhibiting gallbladder cancer cell proliferation by directly targeting HMGA2

International Journal of Oncology

Volumn 45, Issue 6, 2014, Pages 2050-2058

  Zhou, Huading ^a   Guo, Weijie ^b   Zhao, Yingjun ^b   Wang, Yifei ^a   Zha, Ruopeng ^b   Ding, Jie ^b   Liang, Linhui ^b   Hu, Jun ^a   Shen, Hao ^a   Chen, Zongyou ^a   Yin, Baobing ^a   Ma, Baojin ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Gallbladder cancer; HMGA2; miR 26a; Proliferation; Tumor suppressor

Indexed keywords

HIGH MOBILITY GROUP A2 PROTEIN; MESSENGER RNA; MICRORNA 26A; MICRORNA; MIRN26A MICRORNA, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL; CANCER GRADING; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; G1 PHASE CELL CYCLE CHECKPOINT; GALLBLADDER CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; ADULT; ANIMAL; BAGG ALBINO MOUSE; CELL CYCLE; FEMALE; GALLBLADDER TUMOR; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; METABOLISM; MIDDLE AGED; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE; 3' UNTRANSLATED REGION; CANCER PROGNOSIS; CELL CYCLE PROGRESSION; CLINICAL ARTICLE; COLONY FORMATION; GAIN OF FUNCTION MUTATION; HISTOPATHOLOGY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ADULT; ANIMALS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GALLBLADDER NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HMGA2 PROTEIN; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED;

EID: 84899519555     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2360     Document Type: Article

References (28)

1. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
2. Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233, 2009.
3. Croce CM and Calin GA: miRNAs, cancer, and stem cell division. Cell 122: 6-7, 2005.
4. Friedman RC, Farh KK, Burge CB, et al: Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105, 2009.
5. Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20, 2005.
6. Hernando E: microRNAs and cancer: role in tumorigenesis, patient classification and therapy. Clin Transl Oncol 9: 155-160, 2007.
7. Negrini M, Ferracin M, Sabbioni S, et al: MicroRNAs in human cancer: from research to therapy. J Cell Sci 120: 1833-1840, 2007.
8. Chen YL, Huang ZQ, Zhou NX, et al: Clinical analysis of 110 patients with primary gallbladder carcinoma. Zhonghua Zhong Liu Za Zhi 29: 704-706, 2007 (In Chinese).
9. Bao B, Ali S, Banerjee S, et al: Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression. Cancer Res 72: 335-345, 2012.
10. Lu J, He ML, Wang L, et al: MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Cancer Res 71: 225-233, 2011.
11. Zhang B, Liu XX, He JR, et al: Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer. Carcinogenesis 32: 2-9, 2011.
12. Dang X, Ma A, Yang L, et al: MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells. Cancer Genet 205: 113-123, 2012.
13. Kota J, Chivukula RR, O'Donnell KA, et al: Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137: 1005-1017, 2009.
14. Yang X, Liang L, Zhang XF, et al: MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway. Hepatology 58: 158-170, 2013.
15. Slaby O, Redova M, Poprach A, et al: Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients. Genes Chromosomes Cancer 51: 707-716, 2012.
16. Xia X, Cheng A, Akinmade D, et al: The N-terminal 24 amino acids of the p55 gamma regulatory subunit of phosphoinositide 3-kinase binds Rb and induces cell cycle arrest. Mol Cell Biol 23: 1717-1725, 2003.
17. Deng Q, Wang Q, Zong WY, et al: E2F8 contributes to human hepatocellular carcinoma via regulating cell proliferation. Cancer Res 70: 782-791, 2010.
18. Sozzani R, Maggio C, Giordo R, et al: The E2FD/DEL2 factor is a component of a regulatory network controlling cell proliferation and development in Arabidopsis. Plant Mol Biol 72: 381-395, 2010.
19. Hazar-Rethinam M, Cameron SR, Dahler AL, et al: Loss of E2F7 expression is an early event in squamous differentiation and causes derepression of the key differentiation activator Sp1. J Invest Dermatol 131: 1077-1084, 2011.
20. Sirma H, Kumar M, Meena JK, et al: The promoter of human telomerase reverse transcriptase is activated during liver regeneration and hepatocyte proliferation. Gastroenterology 141: 326-337, 2011.
21. Li O, Vasudevan D, Davey CA, et al: High-level expression of DNA architectural factor HMGA2 and its association with nucleosomes in human embryonic stem cells. Genesis 44: 523-529, 2006.
22. Fusco A and Fedele M: Roles of HMGA proteins in cancer. Nat Rev Cancer 7: 899-910, 2007.
23. Ashar HR, Chouinard RA Jr, Dokur M, et al: In vivo modulation of HMGA2 expression. Biochim Biophys Acta 1799: 55-61, 2010.
24. Eda A, Tamura Y, Yoshida M, et al: Systematic gene regulation involving miRNAs during neuronal differentiation of mouse P19 embryonic carcinoma cell. Biochem Biophys Res Commun 388: 648-653, 2009.
25. Ahmed KM, Tsai CY and Lee WH: Derepression of HMGA2 via removal of ZBRK1/BRCA1/CtIP complex enhances mammary tumorigenesis. J Biol Chem 285: 4464-4471, 2010.
26. Cleynen I and Van de Ven WJ: The HMGA proteins: a myriad of functions (Review). Int J Oncol 32: 289-305, 2008.
27. Sgarra R, Zammitti S, Lo Sardo A, et al: HMGA molecular network: from transcriptional regulation to chromatin remodeling. Biochim Biophys Acta 1799: 37-47, 2010.
28. Wang X, Liu X, Li AY, et al: Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers. Clin Cancer Res 17: 2570-2580, 2011.